会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • DNA encoding human cysteine protease
    • 编码人半胱氨酸蛋白酶的DNA
    • US5840562A
    • 1998-11-24
    • US928613
    • 1997-09-12
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • C12N9/64C12N9/48C07H21/04
    • C12N9/6472
    • The present invention provides a polynucleotide (ncp) which identifies and encodes a novel cysteine protease (NCP) expressed in cells of both the adrenal gland and human umbilical vein endothelium. The present invention also provides for antisense molecules and oligomers designed from the nucleotide sequence or its antisense. The invention further provides genetically engineered expression vectors and host cells for the production of purified NCP peptide, antibodies capable of binding to NCP, inhibitors which bind to NCP and pharmaceutical compositions based on NCP specific antibodies or inhibitors. The invention specifically provides for diagnostic assays based on altered ncp expression and which allow identification of such a condition. These assays utilize probes designed from ncp encoding or controlling nucleic acid sequences or antibodies specific for the NCP.
    • 本发明提供了鉴定和编码在肾上腺和人脐静脉内皮的细胞中表达的新型半胱氨酸蛋白酶(NCP)的多核苷酸(ncp)。 本发明还提供由核苷酸序列或其反义设计的反义分子和寡聚体。 本发明进一步提供用于产生纯化的NCP肽,能够结合NCP的抗体,结合NCP的抑制剂和基于NCP特异性抗体或抑制剂的药物组合物的遗传工程表达载体和宿主细胞。 本发明特别提供了基于改变的ncp表达并允许鉴定这种病症的诊断测定法。 这些测定使用从ncp编码或控制核酸序列或针对NCP特异的抗体设计的探针。
    • 4. 发明授权
    • Human cysteine protease
    • 人半胱氨酸蛋白酶
    • US6007997A
    • 1999-12-28
    • US193524
    • 1998-11-17
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • C12N9/64C12Q1/68C07H21/04C12N15/85
    • C12N9/6472
    • The present invention provides a polynucleotide (ncp) which identifies and encodes a novel cysteine protease (NCP) expressed in cells of both the adrenal gland and human umbilical vein endothelium. The present invention also provides for antisense molecules and oligomers designed from the nucleotide sequence or its antisense. The invention further provides genetically engineered expression vectors and host cells for the production of purified NCP peptide, antibodies capable of binding to NCP, inhibitors which bind to NCP and pharmaceutical compositions based on NCP specific antibodies or inhibitors. The invention specifically provides for diagnostic assays based on altered ncp expression and which allow identification of such a condition. These assays utilize probes designed from ncp encoding or controlling nucleic acid sequences or antibodies specific for the NCP.
    • 本发明提供了鉴定和编码在肾上腺和人脐静脉内皮的细胞中表达的新型半胱氨酸蛋白酶(NCP)的多核苷酸(ncp)。 本发明还提供由核苷酸序列或其反义设计的反义分子和寡聚体。 本发明进一步提供用于产生纯化的NCP肽,能够结合NCP的抗体,结合NCP的抑制剂和基于NCP特异性抗体或抑制剂的药物组合物的遗传工程表达载体和宿主细胞。 本发明特别提供了基于改变的ncp表达并允许鉴定这种病症的诊断测定法。 这些测定使用从ncp编码或控制核酸序列或针对NCP特异的抗体设计的探针。